Pacira BioSciences' EPS (Weighted Average and Diluted) rose 10385.85% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.46, marking a year-over-year increase of 12288.56%. This contributed to the annual value of -$2.15 for FY2024, which is 36672.54% down from last year.
Per Pacira BioSciences' latest filing, its EPS (Weighted Average and Diluted) stood at $0.12 for Q3 2025, which was up 10385.85% from -$0.11 recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' EPS (Weighted Average and Diluted) ranged from a high of $0.51 in Q2 2023 and a low of -$3.11 during Q3 2024
Over the past 5 years, Pacira BioSciences' median EPS (Weighted Average and Diluted) value was $0.19 (recorded in 2024), while the average stood at -$0.0.
Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 125000.0% in 2023, then crashed by 145217.39% in 2024.
Over the past 5 years, Pacira BioSciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.11 in 2021, then crashed by 100.0% to -$0.22 in 2022, then surged by 317.48% to $0.48 in 2023, then decreased by 27.5% to $0.35 in 2024, then tumbled by 65.4% to $0.12 in 2025.
Its EPS (Weighted Average and Diluted) stands at $0.12 for Q3 2025, versus -$0.11 for Q2 2025 and $0.1 for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value